ACCESS.
LEGACY.
biomarkers and translate it into diagnostic tools that reach communities
around the world.
FUNDING & RESEARCH PARTNERS





We are building a future in which blood tests can reveal neurodegenerative diseases early — widely accessible to communities around the world. Every diagnosis is the first step towards a cure.
Dr. Thomas K. Karikari
Principal Investigator · Associate Professor of Psychiatry, University of Pittsburgh
Three ways to work with the lab
From mechanistic discovery to assay services, our door is open to academic and clinical partners worldwide.
01
Research
Science & Innovation
See how we decode the biology of blood-based biomarkers for Alzheimer's disease and related dementias.
Explore our science
02
Partnership
Partnering with Karikari Lab
Grants, cohorts, co-authored programs and philanthropic giving — how partners and donors help build our studies.
Partner or donate
03
Services
Laboratory services
Validated fluid biomarker assays available to external investigators through the University of Pittsburgh.
Visit pitt.edu/karikariMEET THE LAB
A two-minute introduction from Thomas Karikari
Why blood-based biomarkers, why Pittsburgh, and why access matters as much as accuracy — in his own words.
Watch the introduction →
Watch the introduction →



